ResearchMoz

Intraocular Lens (IOL): Market Shares, Strategies, and Forecasts, Worldwide, Nanotechnology, 2013 to 2018

Winter Green Research
Published Date » 2013-02-11
No. Of Pages » 293
   
 WinterGreen Research announces that it has published a new study Intraocular Lens (IOL) Market Shares, Strategy, and Forecasts, Worldwide, 2013 to 2018. The 2013 study has 293 pages, 67 tables and figures. Worldwide markets are poised to achieve continuing growth as the aging population worldwide develops cataracts and need Intraocular Lenses (IOL). All older people develop cataracts. 
   
 Cataracts are a clouding of the eye's natural lens that impairs one's ability to see clearly. With two accommodating Intraocular Lens IOLs likely to be approved within the next 12 months, the premium market is again exciting. 
   
 Intraocular lens market driving forces include the aging of the population. With age, all people have cataracts which can be cured with IOL. There is an...
Table of Content

Intraocular Lens (IOL) Executive Summary
Intraocular Lens Market Driving Forces
Cataract Surgical Technology Is Evolving Rapidly
Patient Populations Have Significant Demand for Cataract Surgery
Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
Cataract Surgery Business
Intraocular Lens Market Challenges
World Population Growth
Intraocular Lens Market Shares
Intraocular Lens Market Forecasts

1. Intraocular Lens Market Description and Market Dynamics
1.1 Cataract Surgical Technology Is Evolving Rapidly
1.1.1 Patient Populations Have Significant Demand for Cataract Surgery
1.1.2 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
1.1.3 Cataract Surgery Business
1.1.4 Intraocular Lens Market Challenges
1.2 World Economy Undergoing A Transformation
1.2.1 Global Economic Conditions:
1.2.2 Global Economy Becomes Steadily More Sluggish
1.2.3 Global Economic Conditions Impact Markets

2. Intraocular Lens Market Shares and Forecasts
2.1 Intraocular Lens Market Driving Forces
2.1.1 Cataract Surgical Technology Is Evolving Rapidly
2.1.2 Patient Populations Have Significant Demand for Cataract Surgery
2.1.3 Challenge To Get Wide Acceptance Of A New Lens Once It Is Approved
2.1.4 Cataract Surgery Business
2.1.5 Intraocular Lens Market Challenges
2.1.6 World Population Growth
2.2 Intraocular Lens Market Shares
2.2.1 Novartis / Alcon
2.2.2 Novartis / Alcon Competitive Situation
2.2.3 Novartis / Alcon Competition
2.2.4 Novartis Alcon Multifocal Lenses
2.2.5 Novartis / Alcon
2.2.6 Novartis / Alcon
2.2.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045
2.2.8 LenSx Acquired by Alcon
2.2.9 Abbott Medical Optics
2.2.10  Abbott Medical Optics / Visiogen’s Synchrony
2.2.11  Abbott Tecnis
2.2.12  Abbott TECNIS® IOLs
2.2.13  Bausch & Lomb Presbyopic IOLs
2.2.14  Bausch + Lomb
2.2.15  Bausch + Lomb Eye Surgical Technologies In The Pipeline
2.2.16  Bausch + Lomb: Accommodating IOLs
2.2.17  Bausch + Lomb:  Crystalens IOL
2.2.18  OptiMedica
2.2.19  Staar Acrylic IOL
2.2.20  Staar
2.2.21  Staar Silicone IOLs
2.2.22  Staar® Surgical Company nanoFLEX IOL
2.2.23  Staar Visian
2.2.24  LensAR
2.2.25  PhysIOL's FineVision
2.2.26  IOL Research and New Lenses
2.2.27  ReSTOR Multifocal Toric AcrySof IQ
2.2.28  Abbott Tecnis One-Piece Toric
2.2.29  Lenstec Tetraflex
2.2.30  Calhoun Vision Light-Adjustable Lens
2.2.31  Abbott Visiogen Synchrony
2.2.32  Rayner M-flex T
2.2.33  NuLens DynaCurv
2.2.34  Carl Zeiss AcriLisa Diffractive Multifocal Toric
2.2.35  Bausch + Lomb’s Crystalens Toric
2.2.36  Hoya’s Adoptics
2.3 Intraocular Lens Market Forecasts
2.3.1 Intraocular Lens Market Segment Forecasts
2.3.2 Number of Cataract Surgeries Per Year
2.3.3 Novartis Positioning with Sales and Marketing Resource
2.3.4 Bausch + Lomb Small Incisions
2.3.5 Femtosecond Technology Is Game Changer
2.3.6 Intraocular Lens Unit Analysis
2.3.7 Aspheric Foldable IOL Lens
2.3.8 Intraocular Lens Presbyopia Market Forecasts
2.3.9 Market Trend:  Monofocal IOL Channel Will Be Slowly But Continuously Eroded By The Multifocal IOL
2.3.10  Presbyopia-Correcting Intraocular Lens (IOL)
2.3.11  Premium Channel Surgeons
2.3.12  Market Trend:  Accommodating IOL Channel to Grow
2.3.13  Market Trends:  Diffractive Lenses
2.3.14  Market Trend:  Multifocal IOLs
2.3.15  Market Trend:  Surgical Workstation
2.3.16  Premium IOL Forecasts
2.3.17  Technologies Driving Intraocular Lens IOL Market Growth
2.3.18  Diffractive IOLs
2.3.19  Large Middleclass Population Base Driving Intraocular Lens IOL Market Growth
2.3.20  Nonfoldable Polymethylmethacrylate/Plexiglas Based Lenses To Silicone And Acrylic Based Foldable Lenses
2.3.21  Global Vision Care and Ocular Market
2.4 Intraocular Lens Prices
2.4.1 Premium Lens Technology Reimbursement Trends
2.4.2 CMS Medicare Intorocular Reimbursement Guidelines
2.5 Intraocular Lens Regional Market
2.5.1 Eye Surgical Techniques by Country
2.5.2 United States
2.5.3 Canada
2.5.4 Brazil Cataract Surgical Procedure
2.5.5 Brazilian  Cataract surgeries
2.5.6 China
2.5.7 Toric Lens Implantations On The Rise In Europe
2.5.8 Advanced Technology Intraocular Lens Growth Markets
2.5.9 Cataract Surgery in the UK
2.5.10  Asia-Pacific Cataract Surgery
2.5.11  Cataract Surgery in India
2.5.12  Cataract Surgery Assembly Line Systemm Followed At Aravind Eye Hospitals
2.5.13  Aurolab’s Low-Cost, High-Volume Business Model
2.5.14  Highly Efficient Operations Coupled With Pricing Structure Allow 50% Profit Margin
2.5.15  World Health Organization (WHO),

3. Intraocular Lens (IOL) Product Description
3.1 IOL lenses
3.2 Novartis / Alcon
2.1.1 Novartis / Alcon
2.1.2 Novartis / Alcon Competitive Situation
2.1.3 Novartis / Alcon Competition
2.1.4 Novartis Alcon Multifocal Lenses
2.1.5 Novartis / Alcon
2.1.6 Novartis / Alcon
2.1.7 Novartis / Alcon AcrySof® Toric Intraocular Lens - (IOL) – FDA Approval P930014/S045
2.1.8 LenSx Acquired by Alcon
3.3 Abbott Medical Optics / Visiogen’s Synchrony
3.3.1 Abbott Medical Optics Synchrony
3.3.2 Abbott Medical Optics’
3.3.3 Abbott Medical Optics / Visiogen’s Synchrony Lens
3.4 Bausch & Lomb / Crystalens
3.4.1 Bausch & Lomb Crystalens AO Lens
3.4.2 Bausch + Lomb: Accommodating IOLs
3.4.3 Bausch + Lomb:  Crystalens IOL
3.4.4 Bausch & Lomb Crystalens HD
3.5 Calhoun Vision’s Light Adjustable Lens
3.6 NuLens
3.7 PixelOptics
3.8 Imperial Medical Technologies’
3.9 Presbia’s Flexivue
3.10 Lenstec’s Tetraflex Lens
3.11 Staar
3.11.1  STAAR® Surgical Company nanoFLEX IOL
3.11.2  Staar Elastimide® Silicone Aspheric IOL
3.11.3  Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
3.11.4  Staar Afinity™ Collamer® Aspheric IOL
3.11.5  STAAR Toric™ IOL
3.11.6  Staar Afinity™ and nanoFLEX™ Collamer Aspheric IOLs
3.11.7  Staar Collamer Advantage
3.11.8  Staar nanoFLEX™ Collamer Aspheric Single-Piece IOL
3.11.9  STAAR Surgical Elastimide Silicone Aspheric IOL Model AQ2015A
3.11.10  STAAR Elastimide Lens Model AQ2003V
3.11.11  STAAR Elastimide Lens Model AQ2010V
3.11.12  STAAR Elastimide Lens Model AQ5010V - Low Diopter
3.11.13  STAAR Elastimide Lens Model AQ2017V (Discontinued)
3.11.14  STAAR Elastimide Lens Model AQ1016V (Discontinued)
3.11.15  STAAR Elastic Lens Model AA4204VF
3.11.16  STAAR Elastic Lens Model AA4204VL
3.11.17  STAAR Elastic Lens Model AA4207VF (Discontinued)
3.11.18  STAAR Toric Silicone Single Piece IOL
3.11.19  STAAR Elastic Toric Lens Model AA4203TL
3.11.20  Canon-STAAR Preloaded IOL Model KS-3Ai
3.12 Lxenstec’s Tetraflex
3.12.1  Lxenstec’s Tetraflex Manufactured To A Tenth Of A Diopter Toleranc3-e
3.12.2  Lxenstec Elenza Lens
3.13 Hoya
3.14 Tecnis MF
3.14.1  PowerVision (Belmont, Calif.), Oculentis (Berlin), and PhysIOL (Liège, Belgium
3.14.2  PowerVision's FluidVision
3.14.3  FluidVision
3.15 MPlus by Oculentis
3.16 PhysIOL's FineVision
3.17 WaveTec Vision
3.18 Pediatric Cataract / Intraocular Lenses (IOL)
3.18.1  4 D change in power is needed between ages 10 and 20
3.18.2  Correcting Astigmatism in Pediatric Patients

4. Intraocular Lens (IOL) Technology
4.1 The Human Eye
4.2 Cataracts
4.2.1 Staar Collamer
4.2.2 Cataract Symptoms
4.2.3 Benefits Of Cataract Eye Surgery
4.2.4 How Cataract Eye Surgery Is Performed
4.3 Intraocular Tens Technology
4.3.1 Technologies Driving Intraocular Lens IOL Market Growth
4.4 Aspheric Contact Lenses
4.5 Refractive Disorders
4.6 Studies On The Restor Toric Lens
4.6.1 MNRead Functional Reading Test
4.7 Surgeons Need To Concentrate On Proper Patient Selection
4.8 Mayo Clinic Study of Long-Term Dislocation Of Intraocular Lenses
4.8.1 Obesity Cause of Diabetes and Neuropathy of the Eye

5. Intraocular Lens (IOL) Company Description
5.1 Abbott Laboratories
5.1.1 Abbott Acquired Visiogen with Synchrony Product
5.1.2 Abbott Labs Cataract Company Acquisitions
5.1.3 Abbott Completes Separation of Research-Based Pharmaceuticals Business
5.1.4 Abbott (NYSE: ABT) Separation Of Its Research- Based Pharmaceuticals Business
5.1.5 Abbott Separating Into Two Independent Companies
5.1.6 Abbott Laboratories and Subsidiaries Revenue
5.1.7 Abbott Sales Mix
5.1.8 Abbott Nutritional Market Presence
5.1.9 Abbott Diagnostics Market Presence
5.1.10  Abbott Medical Devices Market Presence
5.1.11  Abbott Strength Through Ability to Innovate
5.1.12  Abbott Revenue
5.1.13  Abbott Medical Optics
5.1.14  Abbott Medical Optics Corneal Products
5.1.15  Abbott Medical Optics Refractive Product Line
5.1.16  Abbott Medical Optics Cataract Products
5.1.17  Abbott Medical Optics Technological Innovation
5.2 Akkolens
5.2.1 AkkoLens Features
5.2.2 AkkoLens Clinical Partners
5.3 Allergan
5.3.1 Allergan Flagship Franchises In Eye Care, Neurosciences,Medical Dermatology And Urologics
5.3.2 Allergan Acquisition of Inamed Corporation
5.3.3 Allergan Specialty Product Lines Focused On High-Growth Markets
5.3.4 Allergan Global in reach. Specialized in focus
5.3.5 Allergan Leading Products
5.3.6 Allergan/  SkinMedica, Inc. Acquisition
5.3.7 Allergan Obesity Intervention
5.4 Aravind
5.4.1 Future of Aravind
5.5 Bausch And Lomb
5.5.1 Bausch + Lomb Vision Care
5.5.2 Bausch + Lomb Pharmaceuticals
5.5.3 Bausch + Lomb Cataract and Vitreoretinal Surgery
5.5.4 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
5.5.5 Bausch + Lomb Technolas® Perfect Vision
5.5.6 Bausch + Lomb Technolas® Perfect Vision Transforming Refractive Surgery
5.5.7 Bausch + Lomb to Acquire Technolas Perfect Vision GmbH
5.5.8 Technolas Perfect Vision
5.6 Biovision
5.7 Elenza
5.8 Kowa Company, Ltd.Environmental & Energy Saving Products
5.9 Hoya
5.9.1 Hoya, Seiko And Epson; Agreements Executed In The Field Of Optical Products Business
5.9.2 Hoya Second Quarter Revenue
5.10 Lenstec
5.11 Novartis Group / Alcon
5.11.1  Novartis Alcon Division
5.11.2  Novartis Revenue
5.11.3  Alcon Cataract Surgery
5.11.4  Alcon Surgical Glaucoma
5.11.5  Alcon Vitreoretinal
5.11.6  Alcon Refractive Surgery
5.11.7  Alcon Acquires Leading Ocular Surgical Guidance Technology
5.11.8  Alcon
5.11.9  Alcon Acquired The Ophthalmic Division of SensoMotoric Instruments (SMI)
5.11.10  Alcon Division Surgical Products
5.11.11  Alcon Ophthalmic Pharmaceuticals
5.11.12  Alcon Products
5.11.13  Alcon Cataract Reimbursement
5.11.14  Alcon Regulation
5.11.15 LenSx Acquired by Alcon
5.12 OptiMedica
5.12.1  Catalys next generation laser cataract surgery platform
5.13 Physiol
5.13.1  Physiol Multifocal IOL FineVision (Micro F) 2
5.14 Rayner
5.14.1  Surgery on 109 Year old Woman Using Rayner IOL
5.15 Staar Surgical
5.15.1  STAAR Surgical Devices Used In Corrective Surgery
5.15.2  STAAR Surgical Minimally Invasive Intraocular Lenses (IOLs).
5.16 WaveTec Vision®
5.16.1  WaveTec Vision Secures $16.5m To Market Cataract Surgery System
5.17 Zeiss –
5.17.1  Zeiss Vision
5.17.2  Zeiss Revenue
5.18 Selected Companies in the Market

List of Tables


Table ES-1 Intraocular Lens Market Driving Forces
Figure ES-2 Advanced Technology Intraocular Lens Growth Drivers
Table ES-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift.
Table ES-3 Intraocular Lens Market Challenges
Table ES-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide,  2012
Figure ES-5 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019
Table 1-1 Cataract Surgery Diverse Market Growth Drivers
Table 1-2 Intraocular Lens Market Challenges
Table 2-1 Intraocular Lens Market Driving Forces
Figure 2-2 Advanced Technology Intraocular Lens Growth Drivers
Table 2-2 Cataract Surgery Diverse Market Growth Drivers Several generations of IOLs have created significant technical advances in the market. Intraocular Lens market challenges are evolving in the context of this dramatic market shift
Table 2-3 Intraocular Lens Market Challenges
Table 2-4 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide,  2012
Table 2-5 Intraocular Lens (IOL) Market Shares, Dollars, Worldwide, 2012
Table 2-6 Novartis Cataract Surgical Techniques
Figure 2-7 Novartis / Alcon Overview of Surgical Franchise
Figure 2-8 Alcon Key Intraocular Lenses (IOLs) Products
Table 2-9 Novartis / Alcon IOL Market Strategic Positioning
Figure 2-10 Bausch + Lomb Crystalens® is an FDA-approved intraocular lens
Table 2-11 ReSTOR’s Acrylic Material Helps Keep It From Rotating Postop
Figure 2-12 Abbott Tecnis Toric IOL
Figure 2-13 Lenstec Tetraflex
Figure 2-14 Abbott Visiogen Synchrony
Figure 2-15 NuLens DynaCurv
Figure 2-16 Intraocular Lens (IOL) Market Forecasts, Dollars, Worldwide, 2013-2019
Table 2-17 Intraocular Lens Market Forecasts Units and Dollars, Worldwide, 2013-2019
Figure 2-18 Low End Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
Figure 2-19 Premium Intraocular Lens (IOL) Market Shipments Forecasts Dollars, Worldwide, 2013-2019
Table 2-20 Intraocular Lens (IOL) Market Forecasts Units and Dollars, Worldwide, 2013-2019
Figure 2-21 Intraocular Lens (IOL), Market Forecasts, Units, Worldwide, 2013-2019
Figure 2-22 Novartis Franchise Dedicated Resources
Figure 2-23 Cataract Surgery Pathophysiology, Prevalence, and Surgical Techniques
Table 2-24 Intraocular Lens Description
Table 2-25 Intraocular Lens Advanced Technology
Figure 2-26 Novartis Commentary on Cataracts as Leading Cause of Reversible Blindness
Figure 2-27 Intraocular Lens (IOL) Regional Market Segments, Dollars,  2012
Table 2-28 Intraocular Lens (IOL) Regional Market Revenue Segments,US and Worldwide, Dollars, Worldwide, 2013-2019
Table 2-29 Intraocular Lens (IOL) Regional Market Revenue Segments,US and Worldwide Percent, Worldwide, 2013-2019
Figure 2-30 Eye Surgical Techniques by Country 
Figure 3-1 Novartis / Alcon Key Intraocular Lenses (IOLs) Products
Table 3-2 Novartis Cataract Surgical Techniques
Figure 3-3 Novartis / Alcon Overview of Surgical Franchise
Table 3-4 Novartis / Alcon IOL Market Strategic Positioning
Table 3-5 Abbott Medical Optics Cataract Products
Table 3-6 Abbott Medical Visiogen’s Synchrony lens Advantages
Table 3-7 Abbott Medical Visiogen’s Synchrony Lens Disadvantages
Figure 3-8 Bausch + Lomb Crystalens® FDA-Approved Intraocular Lens
Figure 3-9 Bausch + Lomb:  Crystalens IOL Features
Figure 3-10 STAAR® Surgical Company nanoFLEX IOL
Figure 3-11 Staar Implantable Collamer® Lens for Quality of Vision
Table 3-12 Staar IOL Products
Figure 3-12 Staar Toric Visual Acuity
Figure 3-13 Hoya Pre-Loaded IOL Delivery System “iSert™
Figure 4-1 Human Eye
Figure 4-2 Staar nanoFLEX
Figure 4-3 Staar nanoFLEX  Collamer has a built in Anti-Reflective Interface
Figure 4-4 Staar Hydrophilic Collamer Ultra-High Water Content Layer On Its Surface Minimizing The Difference In Refractive Index
Figure 4-5Staar nanoFLEX™ Collamer Percentage of Light Reflectance
Figure 4-6 Staar nanoFLEX™ Collamer Single Piece IOL
Figure 4-7 Staar nanoFLEX™ Collamer Incision Size
Figure 4-8 Staar nanoFLEX™ Collamer Protective Layer
Figure 4-9 Staar Afinity 3-Piece Collamer Aspheric IOL Model CQ2015A
Function 4-10 Modulation Transfer Function (MTF) Analysis
Table 4-11 Cataract Symptoms
Table 5-1 AkkoLens Technological Features
Table 5-2 AkkoLens Medical Features
Figure 5-3 Hoya IOL plant in Singapore
Figure 5-4 Novartis / Alcon Positioning in Healthcare
Figure 5-5 Novartis Resource By Segment
Figure 5-6 Novartis Surgical Franchise

List of Figures

NA

Upcoming Reports:

Poland: rubber products market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the rubber products market in Poland and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the rubber products market in Poland, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview...
Poland: market of rods and flat bars
By - Williams and Marshal Strategy
ort presents an elaborate overview of the main market participants, the price fluctuations, the growth and demand drivers of the market and the factors, influencing its development. Last but not least, the report presents a general overview of the economy of Poland in 2008-2012 and a forecast for its development in the medium term. The report on the rods and flat bars market in Poland includes: Analysis and dynamics of the economy of Poland; Forecast for the development of the economy of Poland; Analysis and forecast of market volume and dynamics; Volume, dynamics and analysis of...
Nanomedical Devices and Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
Factors such as rising prevalence of chronic medical conditions in the fields of neurosciences and cardiology, increasing research and development initiatives in the healthcare sector, and technological advancements in the field of medical sciences are responsible for the growth of this market. Increasing demand for personalized medical care and economic development in Asia-Pacific and Latin American countries will fuel the growth of the market in the future. The utilization of the concepts of nanotechnology in the field of medical science, with diagnostic and therapeutic...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Loss recorded due to heavy investments carried out by Amazon
Jul 25, 2014  
Amazon.com Inc has been investing in newer businesses like consumer electronics and digital content, due to which it has been running into losses for some time now. The loss recorded in the second quarter was by far the highest. In 2014, the stock prices have dropped by 10% with reduced investor confidence in the long term growth investments. The shares of this US based online retailer...
LG Electronics To Invest Huge Capital in R&D Project in South Korea
Jul 25, 2014  
LG Electronics Inc will invest USD 1.26 billion in the construction of a new research and development unit in South Korea’s capital city Seoul. The facility is said to be part of LG’s Science Park project. The 170,000 square meters site will be built in Magok, Seoul and work is expected to begin from August. Once the construction is complete and ready by 2020, the park will house...
Russian Consumer Protection Agency Seeks ban on Some McDonalds Products
Jul 25, 2014  
A lawsuit has been filed in a Moscow court by the Russian consumer protection agency to seek ban on some products from McDonald's Corp's burgers menu, along with its ice creams and shakes menu.  A regional branch of the agency has recently filed a lawsuit asking the court to declare a ban on some products due to some inappropriateness in physical-chemical parameters in the...
High-sodium Diet Increases Risks of Cardiovascular Diseases in Type 2 Diabetics
Jul 24, 2014  
A new research has found relation between the amount of salt in diet of diabetics and their chances of suffering from cardiovascular diseases. The research has stated that diabetics who have a high-salt diet are on a higher risk of having a chronic heart disease as compared to the ones who eat less salt.  The study’s findings provide evidences that support the benefits of a...
Strides Arcolab Bags USFDA Approval for Transplant Drug
Jul 24, 2014  
Indian pharmaceutical company Strides Arcolab has received the approval of the USFDA to sell its transplant drug Tacrolimus in the US market. The capsule is an immune-suppressant that is used for preventing organ rejection that may occur in transplant surgeries of organs such as kidneys, heart or liver in some patients.  USFDA has allowed the sale of the tablets in 5 mg, 1 mg and 0.5...